Lack of a direct effect of estrogen on proliferation and differentiation of normal human osteoblast‐like cells

Although osteoblasts contain estrogen receptors, it is unclear whether estrogen has direct effects on osteoblast proliferation and differentiation. We evaluated the effects of 17β‐estradiol treatment (1 pM to 10 nM) on the proliferation and differentiation of cultured normal adult human cells that expressed many of the phenotypic characteristics and hormonal sensitivities of mature osteoblasts (hOB cells). Treatment of hOB cells with estradiol for as long as 144 h did not affect the rate of DNA synthesis and had minimal, if any, effects on differentiated function. Whereas alkaline phosphatase activity was increased by nearly twofold (P < 0.01) when the hOB cells were treated with 1 nM 1,25‐dihydroxyvitamin D3 [1,25‐(OH)2D3], treatment with estradiol had no effect when given alone and did not affect the cells' response to 1,25‐(OH)2D3. Similarly, the release of bone gla protein (BGP, osteocalcin) was induced by treatment with 1,25‐(OH)2D3 (P < 0.05), but estradiol treatment did not affect this response. Cellular levels of mRNA for alkaline phosphatase and BGP were not altered by estradiol treatment. We conclude that estradiol treatment does not have major effects on the growth or differentiation of cultured hOB cells. These results are consistent with previous observations in vivo that indicate estrogen acts principally to decrease bone resorption, not to modulate its formation.

[1]  A. Tashjian,et al.  Direct modulation by estradiol of the response of human bone cells (SaOS-2) to human parathyroid hormone (PTH) and PTH-related protein. , 1989, Endocrinology.

[2]  G. Rodan,et al.  Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones. , 1989, Endocrinology.

[3]  E. Froesch,et al.  Release of insulin-like growth factor carrier proteins by osteoblasts: stimulation by estradiol and growth hormone. , 1989, Biochemical and biophysical research communications.

[4]  N. Rifai,et al.  Biochemical effects of 17β-estradiol on UMR106 cells , 1989 .

[5]  S. Mohan,et al.  Estradiol stimulates in vitro the secretion of insulin-like growth factors by the clonal osteoblastic cell line, UMR106. , 1989, Biochemical and biophysical research communications.

[6]  C. K. Watts,et al.  Stable transfection of the oestrogen receptor gene into a human osteosarcoma cell line. , 1989, Journal of steroid biochemistry.

[7]  K. Mann,et al.  Epitopes of the human erythrocyte Ca2+-Mg2+ ATPase pump in human osteoblast-like cell plasma membranes. , 1988, The Journal of clinical endocrinology and metabolism.

[8]  J. Bourguignon.  Linear growth as a function of age at onset of puberty and sex steroid dosage: therapeutic implications. , 1988, Endocrine reviews.

[9]  R. Jaenisch,et al.  Structure of a full-length cDNA clone for the prepro alpha 1(I) chain of human type I procollagen. , 1988, The Biochemical journal.

[10]  Kenneth G. Mann,et al.  Evidence of estrogen receptors in normal human osteoblast-like cells , 1988 .

[11]  B. Komm,et al.  Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. , 1988, Science.

[12]  E. Froesch,et al.  Enhanced osteoblast proliferation and collagen gene expression by estradiol. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[13]  G. Wesolowski,et al.  Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties. , 1987, Cancer research.

[14]  T. Flynn,et al.  17 beta-estradiol acts directly on the clonal osteoblastic cell line UMR106. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[15]  A. Kahn,et al.  New concepts in bone remodeling: an expanding role for the osteoblast. , 1987, American journal of otolaryngology.

[16]  L C Murphy,et al.  Estrogen induces insulin-like growth factor-I expression in the rat uterus. , 1987, Molecular endocrinology.

[17]  M. Sporn,et al.  Osteoblasts synthesize and respond to transforming growth factor-type beta (TGF-beta) in vitro , 1987, The Journal of cell biology.

[18]  R T Turner,et al.  The effects of ovariectomy and 17β‐estradiol on cortical bone histomorphometry in growing rats , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  R. Jove,et al.  Cell transformation by the viral src oncogene. , 1987, Annual review of cell biology.

[20]  R. Russell,et al.  1,25-Dihydroxyvitamin D3 and human bone-derived cells in vitro: effects on alkaline phosphatase, type I collagen and proliferation. , 1986, Endocrinology.

[21]  C. Slaughter,et al.  Isolation and characterization of a cDNA encoding a human liver/bone/kidney-type alkaline phosphatase. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[22]  V. Rosen,et al.  Isolation of the human gene for bone gla protein utilizing mouse and rat cDNA clones. , 1986, The EMBO journal.

[23]  P. McSheehy,et al.  Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone. , 1986, Endocrinology.

[24]  J. Puzas,et al.  Bone cell phosphotyrosine phosphatase: characterization and regulation by calcitropic hormones. , 1985, Endocrinology.

[25]  C. Dani,et al.  Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. , 1985, Nucleic acids research.

[26]  M. Pittelkow,et al.  Integrated control of growth and differentiation of normal human prokeratinocytes cultured in serum‐free medium: Clonal analyses, growth kinetics, and cell cycle studies , 1984, Journal of cellular physiology.

[27]  K. Mann,et al.  Increase in serum bone gamma-carboxyglutamic acid protein with aging in women. Implications for the mechanism of age-related bone loss. , 1983, The Journal of clinical investigation.

[28]  R. Lindsay,et al.  PREVENTION OF SPINAL OSTEOPOROSIS IN OOPHORECTOMISED WOMEN , 1980, The Lancet.

[29]  M. Sporn,et al.  Autocrine secretion and malignant transformation of cells. , 1980, The New England journal of medicine.

[30]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[31]  W. McGuire,et al.  Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor. , 1978, The Journal of biological chemistry.

[32]  H. Moses,et al.  Nuclear RNA polymerase activities and poly(A)-containing mRNA accumulation in cultured AKR mouse embryo cells stimulated to proliferate. , 1977, Experimental cell research.

[33]  P. Kelly,et al.  Short- and long-term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosis. , 1972, The Journal of clinical investigation.

[34]  R. Diegelmann,et al.  Use of a mixture of proteinase-free collagenases for the specific assay of radioactive collagen in the presence of other proteins. , 1971, Biochemistry.

[35]  R. Heaney.  A unified concept of osteoporosis. , 1965, The American journal of medicine.

[36]  Debono Ef.  OUTPATIENT WAITING TIME. , 1963 .